Predictors of COVID-19 outcome in Parkinson's disease.
Parkinsonism Relat Disord
; 78: 134-137, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-712120
ABSTRACT
INTRODUCTION:
Specific pre-existing medical conditions (e.g. hypertension or obesity), advanced age and male sex appear linked to more severe manifestations of SARS Co-V2 infection, thus raising the question of whether Parkinson's disease (PD) poses an increased risk of morbidity and mortality in COVID-19 patients.METHODS:
In order to describe the outcome of COVID-19 in multi-centre a cohort of PD patients and explore its potential predictors, we gathered the clinical information of 117 community-dwelling patients with COVID-19 followed in 21 tertiary centres in Italy, Iran, Spain, and the UK.RESULTS:
Overall mortality was 19.7%, with a significant effect of co-occurrence of dementia, hypertension, and PD duration.CONCLUSIONS:
The frailty caused by advanced PD poses an increased risk of mortality during COVID-19.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Dementia
/
COVID-19
/
Hospitalization
/
Hypertension
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
/
Europa
Language:
English
Journal:
Parkinsonism Relat Disord
Journal subject:
Neurology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS